# Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion

> **NCT00123292** · PHASE2 · TERMINATED · sponsor: **ThromboGenics** · enrollment: 19 (actual)

## Conditions studied

- Arterial Occlusive Diseases

## Interventions

- **DRUG:** Microplasmin
- **DRUG:** Microplasmin
- **DRUG:** Microplasmin

## Key facts

- **NCT ID:** NCT00123292
- **Lead sponsor:** ThromboGenics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-03
- **Primary completion:** 2007-06
- **Final completion:** 2009-11
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Sponsor's decision not to pursue development of uPLi for vascular conditions
- **Last updated:** 2014-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00123292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00123292, "Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00123292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*